Note: This is not an investment advice but my opinion alone. Please feel free to comment.
VSTM has seen its price drop since it reached a 52 week high (even after its drug was approved by the FDA). I think in the long term VSTM will recover but not before it finishes it ABC correction and reaching the FIB ratio 0.786 where it will fill the gap it made in April 2018.
I will look to initiate a position at this price between $3.50 and $3.18
Comment
⋅
I have update a new idea "VSTM Could go down even more (Part 2)"